Surgical site infection (SSI) is one of the most frequent and fearsome complications in vascular surgery due to its high morbidity and mortality. In addition, SSI is one of the factors related to the development of prosthetic infection. Consequently, it represents a significant increase in hospital stay and healthcare costs. A 2021 meta-analysis on groin SSI prevention strategies in arterial surgeries reported that using intradermal sutures could be associated with a lower SSI rate. The published results from a single-center retrospective study comparing SSI rates before and after implementing an SSI prevention protocol also suggest better outcomes with intradermal suturing. This study aims to assess the SSI incidences of both skin closure techniques in vascular surgery patients undergoing femoral artery approach through a perpendicular groin skin incision.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
225
Skin closure with an intradermal suture using Monosyn® (Braun®) 4/0 absorbable monofilament.
Skin closure with metallic stapling using Visistat® (Weck®) 35W skin stapler.
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Number (percentage) of patients who present a femoral approach SSI* -(superficial and/or deep) up to 28 (±2) after surgery.
According to the National Healthcare Safety Network (NHSN) Classification
Time frame: 28 (±2) days after surgery
Number (percentage) of patients with other surgical wound complications up to 28 (±2) days after surgery.
Complications include but are not limited to seroma, hematoma, lymphorrhagia.
Time frame: 28 (±2) days after surgery
Number (percentage) of patients who develop sepsis up to 28 (±2) days after surgery
Time frame: 28 (±2) days after surgery
Number (percentage) of patients with SSI who develop sepsis up to 28 (±2) days after surgery.
Time frame: 28 (±2) days after surgery
Time of prophylactic antibiotic administration
Time frame: 28 (±2) days after surgery
Types of microorganisms isolated from skin microbiological culture, subcutaneous tissue sample culture, and SSI secretion culture up to 28 (±2) days after surgery.
Time frame: 28 (±2) days after surgery
Types of antibiotic therapy used in patients with SSI
Time frame: 84 (±7) days after surgery
Plasma albumin concentration
Time frame: Baseline visit to 28 (±2) days after surgery
Body Mass Index
Time frame: Baseline visit to 28 (±2) days after surgery
Surgical incision length
Length (in centimeters \[cm\]) of the cutaneous incision performed to gain access to the surgical site. This information will be collected on the day of performing the surgery, once it is over.
Time frame: On the day of performing the surgical procedure
Total surgery duration
Duration (in minutes) of the surgical procedure. This information will be collected on the day of performing the surgery, once it is over.
Time frame: On the day of performing the surgical procedure
Type of hemostatic material used during surgery
This information will be collected on the day of performing the surgery, once it is over.
Time frame: On the day of performing the surgical procedure
Number of days between hospital admission and the surgical intervention
The number of days gone by from hospital admission until the day the surgery is performed. This information will be collected on the day of performing the surgery, once it is over.
Time frame: From the day of hospital admission to the day of performing the surgical procedure
Number (percentage) of patients who present a femoral approach SSI (superficial and/or deep) up to 84 (±7) days after surgery
According to the NHSN classification
Time frame: 84 (±7) days after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.